- Faculty
- BR1DGE
Anastacia Albanese-O'Neill
Breakthrough T1D
Anastasia Albanese-O’Neill, PhD., APRN, CDCES, serves as vice president, medical affairs, at Breakthrough T1D (formerly JDRF) where her team focuses on accelerating clinical adoption of emerging therapies in type 1 diabetes (T1D) and raising awareness about the importance of early detection and clinical trial participation. Prior to joining Breakthrough T1D, Albanese-O’Neill was an assistant professor of pediatrics and nursing at the University of Florida, where she maintained an active research portfolio and clinical practice. Her research has been published in peer-reviewed journals including Diabetes Care, The Lancet, Pediatric Diabetes, and Diabetes Technology & Therapeutics.
Albanese-O’Neill has been a passionate diabetes advocate since her daughter was diagnosed with T1D in 2002, and has provided testimony at congressional hearings, the White House, and in the Florida legislature. She is a co-author on state, national, and international position statements on diabetes in the school setting aimed at reducing discrimination and improving care for students with diabetes. She was recognized as Diabetes Care and Education Specialist of the Year by ADCES in 2023.
